FindTrial
Sign In

Effectiveness of TENS associated with vocal therapy in women with vocal disorders

Effectiveness of the application of low-frequency transcutaneous electrical nerve stimulation associated with vocal therapy in dysphonic women: clinical trial, controlled, randomized and blind - : Transcutaneous Electrical Nerve Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5k95vs
Enrollment
Unknown
Registered
2020-05-20
Start date
2020-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysphonia

Interventions

Group 1 - 18 women with behavioral dysphonia will receive low frequency transcutaneous electrical stimulation (TENS) concomitantly with vocal exercises. Group 2 - 18 women with behavioral dysphonia wi
Behavioural
Other
E02.760.169.063.500.727.862

Sponsors

Faculdade de Odontologia de Bauru da Universidade de São Paulo
Lead Sponsor
Faculdade de Odontologia de Bauru da Universidade de São Paulo
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: women aged between 18 and 50 years old; complaint of vocal alteration; altered voice evidenced by a speech-language auditory perceptual pre-assessment; bilateral vocal nodules or mucosal thickening or edema and glottic cleft on phonation; not having used TENS for any type of treatment

Exclusion criteria

Exclusion criteria: women who had received speech therapy before; over 50 years of age; who reported being or had completed menstrual flow; who reported any general neurological alterations; thyroid gland changes, who had undergone clinical treatment for hormonal control (except contraceptive pill); vocal or surgical laryngeal treatment; heart problems, high blood pressure, hyper or hypothyroidism; smokers; alcoholics

Design outcomes

Primary

MeasureTime frame
Main outcome: Evaluate vocal treatment with TENS associated with vocal exercises regarding vocal quality through perceptual-auditory and vocal acoustic analysis;Expected outcome 3: Evaluate vocal treatment with TENS associated with vocal exercises for voice-related quality of life using the self-assessment protocols QVV and IDV-10;Expected outcome 2: Evaluate vocal treatment with TENS associated with vocal exercises regarding aspects of the larynx, through nasolaryngoscopy—

Secondary

MeasureTime frame
Expected outcome 5: Evaluate vocal treatment with TENS associated with vocal exercises regarding the functionality of the vocal folds by means of Electroglotography, verifying the contact coefficient of the vocal folds;Expected outcome 4: Evaluate vocal treatment with TENS associated with vocal exercises for musculoskeletal pain using a self-assessment protocol—

Countries

Brazil

Contacts

Public ContactLarissa;Larissa Siqueira;Siqueira

Faculdade de Odontologia de Bauru da Universidade de São Paulo;Faculdade de Odontologia de Bauru

larisiqueira_4@hotmail.com;larisiqueira_4@hotmail.com+55-014-3235-8000;+55-014-3235-8000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 9, 2026